Skip to content
Gene2Rx home

Try

Loading…

Search couldn't load. Check your connection and try again, or use the medication lookup.

No pages match .

The medication lookup checks any medication by name, including ones without their own page.

Get my report

Example report. The whole genome example: a public genome from the 1000 Genomes Project, with CYP2D6 Structural Analysis, so you can see what yours will look like. Get your own report

AnestheticsExample report

Methoxyflurane

No known risk variants found

We checked the known malignant hyperthermia genes in your DNA and found no listed risk variants. This doesn't rule out the risk: about half of people who have had this reaction carry no known variant. Tell your anesthesiologist about any personal or family history of reactions to anesthesia.

The genes behind this label

The guidelines read 2 genes for methoxyflurane. Each card shows the two copies this person inherited and what they mean.

RYR1Your two copies: Reference/Reference

Risk geneNo known risk variants found

A muscle channel. Rare changes in it can cause a dangerous reaction to some anesthetics.

This result doesn't change the label.

CACNA1SYour two copies: Reference/Reference

Risk geneNo known risk variants found

A muscle channel. Rare changes in it can cause a dangerous reaction to some anesthetics.

This result doesn't change the label.

What the guidelines say

What each guideline says about your result.

RYR1No known risk variants foundCACNA1SNo known risk variants found

In plain words
We checked the known malignant hyperthermia genes in your DNA and found no listed risk variants. This doesn't rule out the risk: about half of people who have had this reaction carry no known variant. Tell your anesthesiologist about any personal or family history of reactions to anesthesia.
What it means
No known CPIC-listed malignant-hyperthermia-associated variants were identified in RYR1 or CACNA1S in the supplied WGS data. These results do not eliminate the chance that this patient is susceptible to malignant hyperthermia (MH). The genetic cause of about half of all MH survivors, with MH susceptibility confirmed by contracture test, remains unknown (PMID 28902675).
What the guideline suggests
Clinical findings, family history, further genetic testing and other laboratory data should guide use of halogenated volatile anesthetics or depolarizing muscle relaxants.

CPIC reads your RYR1 and CACNA1S results together for methoxyflurane, so this label reflects both genes.

About methoxyflurane

Methoxyflurane is one of the potent volatile anesthetics that CPIC names as malignant hyperthermia (MH) triggers.

Used for
Emergency relief of moderate to severe trauma pain in conscious patients aged 6 and older (UK licence)

Read more about methoxyflurane and genetics

Others in anesthetics

Compare all 8 anesthetics

Don't change a dose on your own. Bring this report to your prescriber or pharmacist. They can weigh it with everything else they know about you.

Back to the example report